STOCK TITAN

CareCloud (CCLD) SEC Filings, Oct 2025-Feb 2026

CCLD NASDAQ

CareCloud, Inc. filings document operating results, Regulation FD presentation materials, governance actions, and capital-structure disclosures for a healthcare technology and revenue cycle management company. The records cover common stock, preferred-stock dividend and security matters, credit facility events, and formal updates tied to financial performance.

CareCloud’s proxy and current reports also disclose shareholder voting matters, bylaw amendments, board and audit committee composition, Nasdaq compliance items, and cybersecurity incident reporting. These filings frame the company’s Healthcare IT and Medical Practice Management activities alongside risk, governance, and public-company reporting obligations.

Rhea-AI Summary

CareCloud, Inc. director Anne Busquet reported a routine equity award vesting and conversion. On January 31, 2026, 6,250 restricted stock units vested and converted into 6,250 shares of common stock at a price of $0.00 under the company’s Amended and Restated Equity Incentive Plan, without payment by Busquet.

After this transaction, she directly holds 287,638 shares of common stock and 33,750 restricted stock units, reflecting ongoing participation in CareCloud’s long‑term incentive program rather than an open‑market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.56%
Tags
insider
-
Rhea-AI Summary

CareCloud director Lawrence Steven Sharnak reported the vesting of equity awards and related share issuance. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of CareCloud common stock at a price of $0 per share under the company’s Amended and Restated Equity Incentive Plan.

After this transaction, Sharnak directly owned 120,250 shares of common stock and 33,750 restricted stock units. The award vested without cash payment by the reporting person, reflecting compensation delivered in company equity rather than cash.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.56%
Tags
insider
-
Rhea-AI Summary

CareCloud, Inc. director Cameron Munter reported the vesting and conversion of restricted stock units into common stock. On January 31, 2026, 6,250 restricted stock units converted into 6,250 shares of common stock at a price of $0.00 under CareCloud’s Amended and Restated Equity Incentive Plan, without payment by Munter.

After this transaction, Munter directly owned 195,250 shares of CareCloud common stock and 33,750 restricted stock units. The filing reflects equity-based compensation vesting rather than an open‑market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.56%
Tags
insider
Rhea-AI Summary

CareCloud, Inc. furnished an update stating that its Board of Directors has declared monthly cash dividends on its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock. These dividends are scheduled for payment in February, March and April 2026, providing continued cash distributions to holders of these preferred shares during that period. Further details, including the specific dividend terms, are contained in a press release dated January 20, 2026 that is incorporated by reference as an exhibit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
current report
-
Rhea-AI Summary

CareCloud, Inc. (CCLD) reported the death of independent director John N. Daly on November 24, 2025. Mr. Daly had served on the Board since July 2014 and was a member of the Audit Committee and chairman of the Compensation Committee.

Because of his passing, the Board no longer has a majority of independent directors and the Audit Committee no longer has at least three members, causing noncompliance with Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2)(A). On November 25, 2025, Nasdaq granted a cure period that runs until the earlier of CareCloud’s next annual shareholder meeting or November 24, 2026. The company has informed Nasdaq that the Board plans to appoint an additional independent director to restore compliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.32%
Tags
current report
-
Rhea-AI Summary

CareCloud (CCLD) director reported an open-market sale. On 11/10/2025, the reporting person sold 15,000 shares of common stock at a weighted average price of $3.41, with individual trades ranging from $3.40 to $3.43.

Following the transaction, the filer beneficially owns 51,750 shares, held directly. The filing notes that detailed trade breakdowns are available upon request.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
insider
Rhea-AI Summary

CareCloud, Inc. filed a Form 8-K to report that it issued a press release on November 10, 2025. The company furnished the release under Regulation FD as Exhibit 99.1, meaning it is provided for information purposes and is not treated as filed for liability purposes under the Exchange Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.74%
Tags
current report
-
Rhea-AI Summary

CareCloud, Inc. filed its Q3 2025 report, showing higher revenue and profitability. Net revenue was $31.067M for the quarter, up from $28.546M a year ago. Operating income was $3.210M and net income was $3.060M. After preferred dividends of $1.365M, net income attributable to common shareholders was $1.695M, or $0.04 per share.

For the nine months, revenue reached $86.076M with net income of $7.910M. Operating cash flow was strong at $19.886M. The balance sheet reflected total assets of $90.576M and shareholders’ equity of $57.804M. As of October 31, 2025, there were 42,397,039 common shares outstanding.

The company closed two acquisitions: Medsphere Systems for $16.5M (including $8.25M cash and $8.25M under a deferred payment that was satisfied on September 3, 2025), adding $11.219M of goodwill; and RevNu with contingent consideration of approximately $649k. CareCloud entered a new $10M secured revolving line with Provident Bank; $6.5M was outstanding at quarter end.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
quarterly report
-
Rhea-AI Summary

CareCloud, Inc. furnished materials related to its results of operations and financial condition. The company provided a press release and an accompanying slide presentation, delivered under Item 2.02 and Item 7.01, respectively. The materials are furnished and not deemed filed under the Exchange Act.

Exhibits include 99.1 (press release dated November 6, 2025), 99.2 (slide presentation dated November 6, 2025), and 104 (Cover Page Inline XBRL). CareCloud’s securities trade on the Nasdaq Global Market under CCLD (common stock) and CCLDO (8.75% Series B Preferred). The report was signed by Interim CFO and Corporate Controller Norman Roth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.63%
Tags
current report
Rhea-AI Summary

CareCloud, Inc. (CCLD) filed an Amendment No. 1 to Form 8-K to complete its earlier acquisition disclosure for Medsphere Systems Corporation. The amendment adds the required financial statements of the acquired business and unaudited pro forma combined information under Item 9.01(a) and (b).

Exhibits include Medsphere’s audited financials as of December 31, 2024 and 2023, unaudited interim financials as of June 30, 2025, and unaudited pro forma condensed combined information covering the acquisitions of Medsphere, RevNu, and Mesa. Other disclosures from the original report remain unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
current report

FAQ

How many CareCloud (CCLD) SEC filings are available on StockTitan?

StockTitan tracks 53 SEC filings for CareCloud (CCLD), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CareCloud (CCLD)?

The most recent SEC filing for CareCloud (CCLD) was filed on November 5, 2026.